Changing epidemiology and mortality in adult congenital heart disease: Looking into the future

Future Cardiology

Volumn 8, Issue 2, 2012, Pages 171-177

  Greutmann, Matthias ^b   Tobler, Daniel ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

congenital heart disease; congenital heart surgery; cyanotic heart disease; Eisenmenger syndrome; Fontan palliation; mortality; tetralogy of Fallot; transposition of the great arteries

Indexed keywords

ADULT; ARTICLE; CHRONIC DISEASE; CONGENITAL HEART DISEASE; CYANOTIC HEART DISEASE; DEMOGRAPHY; FALLOT TETRALOGY; HEART SINGLE VENTRICLE; HEART TRANSPLANTATION; HUMAN; MORTALITY; PRIORITY JOURNAL;

ADULT; AGE FACTORS; FONTAN PROCEDURE; HEART DEFECTS, CONGENITAL; HEART TRANSPLANTATION; HUMANS; MORTALITY, PREMATURE; RISK FACTORS; TETRALOGY OF FALLOT; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84858667985     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.12.6     Document Type: Article

References (44)

1. Warnes CA, Liberthson R, Danielson GK et al. Task force 1: the changing profile of congenital heart disease in adult life. J. Am. Coll. Cardiol. 37, 1170-1175 (2001
2. Botto LD, Correa A, Erickson JD. Racial and temporal variations in the prevalence of heart defects. Pediatrics 107(3), E32 (2001
3. Ferencz C, Rubin JD, McCarter RJ et al. Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study. Am. J. Epidemiol. 121, 31-36 (1985
4. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 39, 1890-1900 (2002 (Pubitemid 34628268)
5. Warnes CA, Williams RG, Bashore TM et al. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: Executive Summary: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease). Circulation 118, 2395-2451 (2008
6. Daliento L, Somerville J, Presbitero P et al. Eisenmenger syndrome. Factors relating to deterioration and death. Eur. Heart J. 19, 1845-1855 (1998 (Pubitemid 28556655)
7. Moons P, Bovijn L, Budts W, Belmans A, Gewillig M. Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation 122, 2264-2272 (2010
8. Gilboa SM, Salemi JL, Nembhard WN, Fixler DE, Correa A. Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation 122, 2254-2263 (2010
9. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation 115, 163-172 (2007 (Pubitemid 46105714)
10. Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing mortality in congenital heart disease. J. Am. Coll. Cardiol. 56, 1149-1157 (2010
11. Oechslin EN, Harrison DA, Connelly MS, Webb GD, Siu SC. Mode of death in adults with congenital heart disease. Am. J. Cardiol. 86, 1111-1116 (2000
12. Verheugt CL, Uiterwaal CS, Van Der Velde ET et al. Turning 18 with congenital heart disease: prediction of infective endocarditis based on a large population. Eur. Heart J. 32, 1926-1934 (2011
13. Nieminen HP, Jokinen EV, Sairanen HI. Causes of late deaths after pediatric cardiac surgery: a population-based study. J. Am. Coll. Cardiol. 50, 1263-1271 (2007 (Pubitemid 47405126)
14. Lamour JM, Addonizio LJ, Galantowicz ME et al. Outcome after orthotopic cardiac transplantation in adults with congenital heart disease. Circulation 100(19 Suppl.), II200-II205 (1999 (Pubitemid 29523535)
15. Greutmann M, Pretre R, Furrer L et al. Heart transplantation in adolescent and adult patients with congenital heart disease: a case-control study. Transplant. Proc. 41, 3821-3826 (2009
16. Irving C, Parry G, O'SulliVan J et al. Cardiac transplantation in adults with congenital heart disease. Heart 96, 1217-1222 (2010
17. Galie N, Beghetti M, Gatzoulis MA et al. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation 114, 48-54 (2006 (Pubitemid 44305274)
18. Dimopoulos K, Inuzuka R, Goletto S et al. Improved survival among patients with Eisenmenger syndrome receiving adVanced therapy for pulmonary arterial hypertension. Circulation 121, 20-25 (2010
19. Hickey EJ, Veldtman G, Bradley TJ et al. Late risk of outcomes for adults with repaired tetralogy of Fallot from an inception cohort spanning four decades. Eur. J. Cardiothorac. Surg. 35, 156-164; discussion 164 (2009
20. Nollert G, Fischlein T, Bouterwek S, Bohmer C, Klinner W, Reichart B. Long-term survival in patients with repair of tetralogy of Fallot: 36 year follow-up of 490 survivors of the first year after surgical repair. J. Am. Coll. Cardiol. 30, 1374-1383 (1997
21. Murphy JG, Gersh BJ, Mair DD et al. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N. Engl. J. Med. 329, 593-599 (1993 (Pubitemid 23244809)
22. Gatzoulis MA, Balaji S, Webber SA et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 356, 975-981 (2000
23. Yalonetsky S, Horlick EM, Osten MD, Benson LN, Oechslin EN, Silversides CK. Clinical characteristics of coronary artery disease in adults with congenital heart defects. Int. J. Cardiol. doi:10.1016/ j.ijcard.2011.07.021 (2011) (Epub ahead of print
24. Buechel ER, Dave HH, Kellenberger CJ et al. Remodelling of the right ventricle after early pulmonary valve replacement in children with repaired tetralogy of Fallot: assessment by cardiovascular magnetic resonance. Eur. Heart J. 26, 2721-2727 (2005 (Pubitemid 41746695)
25. Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am. J. Cardiol. 95, 779-782 (2005 (Pubitemid 40332662)
26. Oosterhof T, Van Straten A, Vliegen HW et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation 116, 545-551 (2007 (Pubitemid 47450263)
27. Harrild DM, Berul CI, Cecchin F et al. Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia. Circulation 119, 445-451 (2009
28. de Leval MR, Deanfield JE. Four decades of Fontan palliation. Nat. Rev. Cardiol. 7, 520-527 (2010
29. Norwood WI, Kirklin JK, Sanders SP. Hypoplastic left heart syndrome: experience with palliative surgery. Am. J. Cardiol. 45, 87-91 (1980 (Pubitemid 10201782)
30. Diller GP, Giardini A, Dimopoulos K et al. Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patients. Eur. Heart J. 31, 3073-3083 (2010
31. Khairy P, Fernandes SM, Mayer JE Jr et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 117, 85-92 (2008 (Pubitemid 350291185)
32. Jayakumar KA, Addonizio LJ, Kichuk-Chrisant MR et al. Cardiac transplantation after the Fontan or Glenn procedure. J. Am. Coll. Cardiol. 44, 2065-2072 (2004 (Pubitemid 39473293)
33. Mustard WT. Successful two-stage correction of transposition of the great vessels. Surgery 55, 469-472 (1964
34. Senning A. Surgical correction of transposition of the great vessels. Surgery 45, 966-980 (1959
35. Jatene AD, Fontes VF, Paulista PP et al. Successful anatomic correction of transposition of the great vessels. A preliminary report. Arq. Bras. Cardiol. 28, 461-464 (1975
36. Williams WG, McCrindle BW, Ashburn DA, Jonas RA, Mavroudis C, Blackstone EH. Outcomes of 829 neonates with complete transposition of the great arteries 12-17 years after repair. Eur. J. Cardiothorac. Surg. 24, 1-9; discussion 9-10 (2003
37. Oechslin E, Jenni R. 40 years after the first atrial switch procedure in patients with transposition of the great arteries: long-term results in Toronto and Zurich. Thorac Cardiovasc. Surg. 48, 233-237 (2000
38. Dos L, Teruel L, Ferreira IJ et al. Late outcome of Senning and Mustard procedures for correction of transposition of the great arteries. Heart 91, 652-656 (2005 (Pubitemid 40559361)
39. Schwerzmann M, Salehian O, Harris L et al. Ventricular arrhythmias and sudden death in adults after a Mustard operation for transposition of the great arteries. Eur. Heart J. 30, 1873-1879 (2009
40. Khairy P, Harris L, Landzberg MJ et al. Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study. Circ. Arrhythm. Electrophysiol. 1, 250-257 (2008
41. Roos-Hesselink JW, Meijboom FJ, Spitaels SE et al. Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22-29 years). Eur. Heart J. 25, 1264-1270 (2004 (Pubitemid 38891578)
42. Mongeon FP, Connolly HM, Dearani JA, Li Z, Warnes CA. Congenitally corrected transposition of the great arteries ventricular function at the time of systemic atrioventricular valve replacement predicts long-term ventricular function. J. Am. Coll. Cardiol. 57, 2008-2017 (2011
43. Scherptong RW, Vliegen HW, Winter MM et al. Tricuspid valve surgery in adults with a dysfunctional systemic right ventricle: repair or replace? Circulation 119, 1467-1472 (2009
44. Tobler D, Williams WG, Jegatheeswaran A et al. Cardiac outcomes in young adult survivors of the arterial switch operation for transposition of the great arteries. J. Am. Coll. Cardiol. 56, 58-64 (2010)